Raffles Medical Group Ltd. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company reported revenue was SGD 120,202,000 against SGD 120,088,000 a year ago. Profit from operating activities was SGD 20,271,000 against SGD 19,578,000 a year ago. Profit before tax was SGD 20,281,000 against SGD 19,796,000 a year ago. Profit attributable to owners of the company was SGD 16,891,000 against SGD 16,763,000 a year ago. Diluted earnings per share were 0.95 cents against 0.95 cents a year ago. EBITDA was SGD 24,955,000 against SGD 23,254,000 a year ago. Net cash from operating activities was SGD 18,869,000 against SGD 26,326,000 a year ago. Purchase of property, plant and equipment was SGD 7,802,000 against SGD 2,755,000 a year ago.

For the six months, the company reported revenue was SGD 240,391,000 against SGD 235,003,000 a year ago. Profit from operating activities was SGD 39,162,000 against SGD 37,665,000 a year ago. Profit before tax was SGD 39,138,000 against SGD 38,065,000 a year ago. Profit attributable to owners of the company was SGD 32,703,000 against SGD 32,308,000 a year ago. Diluted earnings per share were 1.84 cents against 1.83 cents a year ago. Net asset value per ordinary share 42.42 cents against 41.45 cents a year ago.

For the quarter, property, plant and equipment written off was SGD 18,000 against SGD 23,000 a year ago.

Based on the current economic outlook and barring unforeseen circumstances, the Directors expect the Group to grow and remain profitable in 2018.